As of 2026-03-23, the Intrinsic Value of Atossa Therapeutics Inc (ATOS) is -17.53 USD. This Atossa valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.61 USD, the upside of Atossa Therapeutics Inc is -412.41%.
Based on its market price of 5.61 USD and our intrinsic valuation, Atossa Therapeutics Inc (ATOS) is overvalued by 412.41%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.53 - -17.53 | -17.53 | -412.41% |
| P/E | (64.43) - (75.01) | (70.98) | -1365.3% |
| DDM - Stable | (19.50) - (69.30) | (44.40) | -891.4% |
| DDM - Multi | (14.48) - (42.18) | (21.81) | -488.7% |
| Market Cap (mil) | 48.30 |
| Beta | 1.89 |
| Outstanding shares (mil) | 8.61 |
| Enterprise Value (mil) | -3.54 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.57% |
| Cost of Debt | 5.00% |
| WACC | 8.12% |